This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Institut Claudius Regaud, National Institute of Health and Medical Research, Université Paul Sabatier (Toulouse III). Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 6 
2 out of 1,853 
2 out of 162 
Years Active: 2020-2022
Title: Nicolas Bery: Innovator in Antibody Technology
Introduction
Nicolas Bery is a prominent inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 2 patents to his name, Bery's work focuses on therapeutic and diagnostic applications.
Latest Patents
Bery's latest patents include the invention of active form specific anti-Rho GTPase conformational single domain antibodies. These antibodies are designed for use in therapeutic and diagnostic fields. The invention details a single domain antibody wherein the amino acid sequences of CDR1-IMGT, CDR2-IMGT, and CDR3-IMGT exhibit at least 90% identity with specific sequences defined in Table B. This innovation holds promise for advancing medical treatments and diagnostics.
Career Highlights
Throughout his career, Nicolas Bery has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Claudius Regaud Institute (Institut Claudius Regaud). His work in these organizations has allowed him to develop and refine his expertise in antibody technology.
Collaborations
Bery has collaborated with notable colleagues, including Aurelien Olichon and Laura Keller. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Nicolas Bery is a distinguished inventor whose work in antibody technology has the potential to impact therapeutic and diagnostic fields significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile